Dear Editor, Giant cell arteritis (GCA) can lead to devastating ophthalmic complications, including sudden complete loss of vision due to anterior ischemic optic neuropathy (AION) secondary to inflammation and occlusion of the short posterior ciliary arteries, which supply the optic nerve head [1, 2]. Ischemia results in retinal changes, such as nerve fiber layer thickening, structural loss and optic disc edema [3, 4]. Assessing ophthalmic involvement in GCA remains challenging. Non-invasive optical coherence tomography angiography (OCTA) of the eye enables us to visualize the retinal and choroidal microcirculation [5, 6]. Additionally, we have recently shown that transorbital ultrasound (TOS) reveals changes in the ocular perfusion of symptomatic eyes in GCA patients [7]. Building on this cohort, we present the first study comparing vascular ultrasound, TOS, and OCTA findings in newly diagnosed GCA patients. The study enrolled newly diagnosed and untreated GCA patients from the Rheumatology Department at the University Hospital Bonn, Germany. Diagnoses were made by a board-certified rheumatologist with patients further meeting the ACR-EULAR classification criteria [8] following ethics approval (ethics committee of the University Hospital Bonn, reference number: 097/18, october 2018). Demographic, clinical, and laboratory data were assessed. Each patient underwent a comprehensive ultrasound examination of superficial temporal, facial, axillary, carotid, and vertebral arteries, along with TOS using a Logiq S8 (2018; GE Healthcare; 6-15 MHz/ 8-18 MHz probes). Flow velocities of the central retinal artery (CRA), including peak systolic velocity (PSV), end diastolic velocity (EDV), resistance index (RI), and optic nerve diameter (OND) were assessed as described previously [7]. OCTA imaging was performed in one eye per participant, prioritizing